{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:08:31Z","timestamp":1790633311656,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The association of circulating lipids with breast cancer is being debated. The objective of this study was to examine the relationship between abnormal plasma lipids and breast cancer risk in Bangladeshi women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a case-control study designed using a population of 150 women (50 women in each group). The lipid levels of women with breast cancer were compared to the lipid levels of women with benign breast disease (control group 1) and healthy women (control group 2). Study samples were collected from the Department of Surgery, Bangabandhu Sheikh Mujib Medical University, for a period of 1\u2009year. Ethical measures were in compliance with the current Declaration of Helsinki. Statistical analysis was performed with SPSS version 26.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All of the comparison groups shared similar sociodemographic, anthropometric and obstetric characteristics. The incidence of dyslipidemia was significantly higher in breast cancer patients (96%) than in healthy women (84%) and patients with benign breast disease (82%) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 for both). The levels of total cholesterol, triglycerides, and low-density lipoprotein (LDL) cholesterol among the breast cancer patient group were significantly higher than those among both benign breast disease patients and healthy women (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), except for high-density lipoprotein (HDL) cholesterol. Adjusting for other factors, body mass index (BMI) (kg\/m<jats:sup>2<\/jats:sup>) (&gt;\u200923) [OR 53.65; 95% CI: 5.70\u2013504.73; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001] and total cholesterol (mg\/dl) (\u2265 200) [OR 16.05; 95% CI: 3.13\u201382.29; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001] were independently associated with breast cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Total cholesterol and BMI are independent predictors of breast cancer risk among Bangladeshi women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01480-2","type":"journal-article","created":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T13:02:53Z","timestamp":1621688573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Association of hyperlipidemia with breast cancer in Bangladeshi women"],"prefix":"10.1186","volume":"20","author":[{"given":"Fatama Akter","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Faridul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz Tabassum","family":"Prova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbuba","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iffat","family":"Sharmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazi Mazharul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Kamrul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0707-0437","authenticated-orcid":false,"given":"Md. Abdullah Saeed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Mostafizur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,22]]},"reference":[{"key":"1480_CR1","unstructured":"The ASCO Post Staff. GLOBOCAN. Database provides latest global data on cancer burden. Cancer Deaths. 2021;2020 https:\/\/ascopost.com\/news\/december-2020\/globocan-2020-database-provides-latest-global-data-on-cancer-burden-cancer-deaths\/."},{"issue":"8","key":"1480_CR2","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Heal. 2020;8(8):e1027\u201337. https:\/\/doi.org\/10.1016\/S2214-109X(20)30215-1.","journal-title":"Lancet Glob Heal"},{"key":"1480_CR3","unstructured":"Talukder MH, Jabeen S, Islam MJ, Karim N, Shaheen S, Alam AS, et al. Cancer Registry Report National Institue of Cancer Research and Hospital 2005-2007. 2009. https:\/\/www.researchgate.net\/publication\/279851472_Cancer_Registry_Report_2005-2007."},{"key":"1480_CR4","unstructured":"NIRCH. Cancer registry report national institute of cancer research and hospital 2008\u20132010. 2013; http:\/\/nicrh.dghs.gov.bd\/about-us."},{"key":"1480_CR5","unstructured":"Breast Cancer Facts & Figures 2019\u20132020 by American Cancer society, 2020;\u00a0[cited 2021 Jan 04]. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/breast-cancer-facts-and-figures-2019-2020.pdf."},{"issue":"1","key":"1480_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12916-020-01797-2","volume":"18","author":"M Escala-Garcia","year":"2020","unstructured":"Escala-Garcia M, Morra A, Canisius S, Chang-Claude J, Kar S, Zheng W, et al. Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. BMC Med. 2020;18(1):327. https:\/\/doi.org\/10.1186\/s12916-020-01797-2.","journal-title":"BMC Med"},{"key":"1480_CR7","unstructured":"Breast Cancer Risk and Environmental Factors. NIH.\u00a0[cited 2021 Jan 04]. https:\/\/www.niehs.nih.gov\/health\/materials\/environmental_factors_and_breast_cancer_risk_508.pdf."},{"issue":"6","key":"1480_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/jcm8060853","volume":"8","author":"L Ced\u00f3","year":"2019","unstructured":"Ced\u00f3 L, Reddy ST, Mato E, Blanco-Vaca F, Escol\u00e0-Gil JC. HDL and LDL: potential new players in breast cancer development. J Clin Med. 2019;8(6):853. https:\/\/www.mdpi.com\/2077-0383\/8\/6\/853. https:\/\/doi.org\/10.3390\/jcm8060853.","journal-title":"J Clin Med"},{"issue":"11","key":"1480_CR9","doi-asserted-by":"publisher","first-page":"e0142669","DOI":"10.1371\/journal.pone.0142669","volume":"10","author":"H Ni","year":"2015","unstructured":"Ni H, Liu H, Gao R. Serum lipids and breast cancer risk: a meta-analysis of prospective cohort studies. PLoS One. 2015;10(11):e0142669.","journal-title":"PLoS One"},{"issue":"8","key":"1480_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/sj.ijo.0802664","volume":"28","author":"MP Cleary","year":"2004","unstructured":"Cleary MP, Grande JP, Maihle NJ. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-\u03b1 mice. Int J Obes. 2004;28(8):956\u201362. https:\/\/doi.org\/10.1038\/sj.ijo.0802664.","journal-title":"Int J Obes"},{"issue":"1","key":"1480_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","volume":"178","author":"G Llaverias","year":"2011","unstructured":"Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol. 2011;178(1):402\u201312. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.005.","journal-title":"Am J Pathol"},{"issue":"10","key":"1480_CR12","doi-asserted-by":"publisher","first-page":"e46973","DOI":"10.1371\/journal.pone.0046973","volume":"7","author":"M Khaidakov","year":"2012","unstructured":"Khaidakov M, Mehta JL. Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21. PLoS One. 2012;7(10):e46973.","journal-title":"PLoS One"},{"issue":"12","key":"1480_CR13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","volume":"29","author":"CM Kitahara","year":"2011","unstructured":"Kitahara CM, Berrington de Gonz\u00e1lez A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011;29(12):1592\u20138. https:\/\/doi.org\/10.1200\/JCO.2010.31.5200.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1480_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/02841868809090315","volume":"27","author":"SA Tournberg","year":"1988","unstructured":"Tournberg SA, Holm LE, Carstensen JM. Breast cancer risk in relation to serum cholesterol, serum Beta-lipoprotein, height, weight, and blood pressure. Acta Oncol (Madr). 1988;27(1):31\u20137. https:\/\/doi.org\/10.3109\/02841868809090315.","journal-title":"Acta Oncol (Madr)"},{"issue":"5","key":"1480_CR15","doi-asserted-by":"publisher","first-page":"djv032","DOI":"10.1093\/jnci\/djv032","volume":"107","author":"LJ Martin","year":"2015","unstructured":"Martin LJ, Melnichouk O, Huszti E, Connelly PW, Greenberg CV, Minkin S, et al. Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. JNCI J Natl Cancer Inst. 2015;107(5):djv032.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"2","key":"1480_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10654-014-9884-5","volume":"29","author":"M His","year":"2014","unstructured":"His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol. 2014;29(2):119\u201332. https:\/\/doi.org\/10.1007\/s10654-014-9884-5.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"1480_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3923\/pjbs.2009.332.338","volume":"12","author":"WKBA Owiredu","year":"2009","unstructured":"Owiredu WKBA, Donkor S, Addai BW, Amidu N. Serum lipid profile of breast cancer patients. Pakistan J Biol Sci. 2009;12(4):332\u20138. https:\/\/doi.org\/10.3923\/pjbs.2009.332.338.","journal-title":"Pakistan J Biol Sci"},{"key":"1480_CR18","unstructured":"College of American Pathologist. Cancer protocol templates. 2021; [cited 2021 Apr 11]. Available from: https:\/\/www.cap.org\/protocols-and-guidelines\/cancer-reporting-tools\/cancer-protocol-templates."},{"key":"1480_CR19","unstructured":"American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed: Springer Nature; 2017. p. 589\u2013625."},{"key":"1480_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO expert consultation","year":"2004","unstructured":"WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"key":"1480_CR21","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).\u00a0Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421. https:\/\/www.ahajournals.org\/doi\/10.1161\/circ.106.25.3143.","DOI":"10.1161\/circ.106.25.3143"},{"issue":"2","key":"1480_CR22","first-page":"491","volume":"19","author":"DR Pandeya","year":"2018","unstructured":"Pandeya DR, Rajbhandari A, Nepal M, Abdalhabib EK, Bhatta M, Sen MS, et al. Comparative study of serum lipid profiles in nepalese cancer patients attending a tertiary care hospital. Asian Pacific J Cancer Prev. 2018;19(2):491\u20135.","journal-title":"Asian Pacific J Cancer Prev."},{"issue":"12","key":"1480_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tem.2014.10.001","volume":"25","author":"ER Nelson","year":"2014","unstructured":"Nelson ER, Chang C, McDonnell DP. Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab. 2014;25(12):649\u201355. https:\/\/doi.org\/10.1016\/j.tem.2014.10.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1480_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13058-018-1066-z","volume":"20","author":"CH Beckwitt","year":"2018","unstructured":"Beckwitt CH, Brufsky A, Oltvai ZN, Wells A. Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res. 2018 Dec;20(1):144. https:\/\/doi.org\/10.1186\/s13058-018-1066-z.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"1480_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0051446","volume":"7","author":"Z Cheraghi","year":"2012","unstructured":"Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti IA. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One. 2012;7(12):1\u20139.","journal-title":"PLoS One"},{"key":"1480_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/BCTT.S279291","volume":"12","author":"G Kumie","year":"2020","unstructured":"Kumie G, Melak T, Baynes HW. The association of serum lipid levels with breast cancer risks among women with breast cancer at felege hiwot comprehensive specialized hospital, Northwest Ethiopia. Breast Cancer Targets Ther. 2020;12:279\u201387. https:\/\/doi.org\/10.2147\/BCTT.S279291.","journal-title":"Breast Cancer Targets Ther"},{"issue":"4","key":"1480_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/S0100-720320140050.0002","volume":"36","author":"\u00c9P de Sousa-e-Silva","year":"2014","unstructured":"de Sousa-e-Silva \u00c9P, Conde DM, Costa-Paiva L, Martinez EZ, Pinto-Neto AM. Risco cardiovascular em mulheres de meia-idade com c\u00e2ncer de mama: Uma compara\u00e7\u00e3o entre dois modelos de risco. Rev Bras Ginecol e Obstet. 2014;36(4):157\u201362. https:\/\/doi.org\/10.1590\/S0100-720320140050.0002.","journal-title":"Rev Bras Ginecol e Obstet"},{"issue":"1","key":"1480_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-017-0646-8","volume":"17","author":"X Li","year":"2018","unstructured":"Li X, Liu ZL, Wu YT, Wu H, Dai W, Arshad B, et al. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy. Lipids Health Dis. 2018;17(1):1\u20136.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"1480_CR29","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.18203\/2349-2902.isj20193603","volume":"6","author":"M Prabakar","year":"2019","unstructured":"Prabakar M, Prakasam N, Reshma S, Loganathan K, Palani V. A clinical study of serum lipid profile in benign breast disease in a tertiary care hospital. Int Surg J. 2019;6(9):3162.","journal-title":"Int Surg J"},{"issue":"2","key":"1480_CR30","first-page":"PC01","volume":"9","author":"V Kumar","year":"2015","unstructured":"Kumar V, Singh A, Sidhu DS, Panag KMDS. A comparitive study to evaluate the role of serum lipid levels in aetiology of carcinoma breast. J Clin Diagnostic Res. 2015;9(2):PC01\u20133.","journal-title":"J Clin Diagnostic Res"},{"issue":"06","key":"1480_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4172\/2161-1009.1000117","volume":"01","author":"J Peela","year":"2012","unstructured":"Peela J, Jarari A. The relationship between serum lipids and breast Cancer in Libya. Biochem Anal Biochem. 2012;01(06):10\u20132.","journal-title":"Biochem Anal Biochem"},{"issue":"1","key":"1480_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52113\/1\/6.1\/19.1-12","volume":"6","author":"AA Abd","year":"2019","unstructured":"Abd AA, Nile AK, Al-Wasiti EA, Hussein MM. Assessment of lipid profile parameters in women with benign and malignant breast tumor. Muthanna Med J. 2019;6(1):1\u201313.","journal-title":"Muthanna Med J"},{"issue":"9","key":"1480_CR33","first-page":"2475","volume":"19","author":"HMK Akalanka","year":"2018","unstructured":"Akalanka HMK, Ekanayake S, Samarasinghe K. Could anthropometric and lipid parameters reflect susceptibility to breast cancer? Comparison of newly diagnosed breast cancer and apparently healthy women. Asian Pacific J Cancer Prev. 2018;19(9):2475\u201380.","journal-title":"Asian Pacific J Cancer Prev"},{"key":"1480_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/IJGM.S40826","volume":"6","author":"FZ Laamiri","year":"2013","unstructured":"Laamiri FZ, Otmani A, Ahid S, Barkat A. Lipid profile among Moroccan overweight women and breast cancer: a case-control study. Int J Gen Med. 2013;6:439\u201345. https:\/\/doi.org\/10.2147\/IJGM.S40826.","journal-title":"Int J Gen Med"},{"issue":"5","key":"1480_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1467-789X.2007.00396.x","volume":"8","author":"L Vona-Davis","year":"2007","unstructured":"Vona-Davis L, Howard-Mcnatt M, Rose DP. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev. 2007;8(5):395\u2013408. https:\/\/doi.org\/10.1111\/j.1467-789X.2007.00396.x.","journal-title":"Obes Rev"},{"issue":"2","key":"1480_CR36","first-page":"110","volume":"29","author":"MA \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk MA, Ke\u00e7eci M, K\u00f6mo\u011flu S, Eryilmaz M, Sertba\u015f YS, Sertba\u015f M, et al. Hyperlipidemia and mammographic breast density in post-menopausal women. South Clin Istanbul Eurasia. 2018;29(2):110\u20134.","journal-title":"South Clin Istanbul Eurasia"},{"issue":"3","key":"1480_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12282-018-0857-5","volume":"25","author":"SS Nazari","year":"2018","unstructured":"Nazari SS, Mukherjee P. An overview of mammographic density and its association with breast cancer. Breast Cancer. 2018;25(3):259\u201367. https:\/\/doi.org\/10.1007\/s12282-018-0857-5.","journal-title":"Breast Cancer"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01480-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01480-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01480-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T13:06:51Z","timestamp":1621688811000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01480-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,22]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01480-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,22]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB), BSMMU. Reference number: BSMMU\/2018\/11716. Informed written consent was ensured before participation of all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}